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ABSTRACT: Strategies for endosomal escape and access to the
cell nucleus are highly sought for nanocarriers to deliver their load
efficiently following endocytosis. In this work, we have studied the
uptake and intracellular trafficking of a polycationic polyamido-
amine (PAA) endowed with a luminescent Ru complex, Ru−
PhenAN, that shows unique trafficking to the cell nucleus. Live cell
imaging confirmed the capacity of this polymer to access the
nucleus, excluding artifacts due to cell fixation, and clarified that
the mechanism of escape is light-triggered and relies on the
presence of the Ru complexes and their capacity to absorb light
and act as photosensitizers for singlet oxygen production. These
results open up the possibility to use PAA−ruthenium complexes
for targeted light-triggered delivery of genetic material or drugs to
the cytosol and nucleus.
KEYWORDS: polyamidoamines, luminescent ruthenium complexes, nuclear trafficking, endosomal escape, light-triggered escape
■ INTRODUCTION
Nanomedicine holds great promise to change the way drugs are
delivered to their target, owing to the use of nanosized drug
carriers capable to enter cells and be trafficked intracellularly via
energy-dependent pathways.1,2 This is very different from the
way most drugs reach their target, often based simply on their
solubility and partition coefficients in lipids and water.3−5 Since
the very first examples of lipid-based drug carriers like Doxil,6
research in this field has continued to be extremely active and
several other products have reached the market.7 However, it is
also known that drug delivery remains rather challenging and
several factors are still limiting its potential.8−10
Among such factors, it has emerged that most nanosized
carriers entering cells via endocytosis are later trafficked along
the endolysosomal pathway to the lysosomes, where the low pH
and abundant proteases can degrade and destroy the
internalized cargo.5,11 This can be a dead-end for many drug
carriers and their load, especially considering that in many cases
drugs need to be able to reach their cellular targets in the cytosol
or other cell compartments, including the nucleus. Strategies to
escape the endosomes and lysosomes are being investigated via
mechanisms such as the so-called proton sponge effect or by
taking inspiration from toxins and viruses capable of hijacking
the endo-lysosomal pathway.11,12 For instance, for gene therapy
and other therapies based on the delivery of DNA or small
interfering RNA molecules, several viral and nonviral vectors
have been investigated to try to deliver the genetic material to
the cell nucleus or cytosol.12
Cationic polymers and lipids are often used for this
purpose,13−15 because of their capacity to complex the
negatively charged DNA or RNA molecules while also showing
to promote endosomal escape. The mechanisms by which this is
achieved are often unclear and can include proton sponge effects
or fusion with the endosomal membrane to release the cargo in
the cytosol, among others.16 This is often a consequence of
differences in protonation levels, as the pH lowers along the
endo-lysosomal pathway.17,18 Similar endosomal escape strat-
egies can still be limited by low efficiency as often only very few
events of endosomal escape are observed and most of the
material still ends in the lysosomes. In contrast, in other cases,
highly cationic molecules can be limited by high toxicity because
of their charge or because they may promote excessive rupture
events in the endosome and lysosomes, leading ultimately to cell
death.19,20
Among the many polymer species employed as gene delivery
vectors, linear polyamidoamines (PAAs) are very interesting and
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promising materials. They are synthetic water-soluble biode-
gradable polymers that can be designed to be highly
biocompatible.21,22 All of them show different charge distribu-
tion profiles as a function of pH.23 Most PAAs have very low
toxicities, with LD50 values in vitro 2 orders of magnitude higher
than other cationic polymers, such as polyethyleneimine,24
poly(L- lysine),25 and polyamidoamine dendrimers
(PAMAM).26 The ability of linear PAAs to promote gene
transfection in vitro was already demonstrated for some
PAAs.27,28 In addition, a linear amphoteric, but prevailingly
cationic, homopolymer, named AGMA1, has also been shown to
promote gene transfection in vivo29 and to mediate the efficient
delivery of siRNA in vitro.30 More recently, another amphoteric
copolymer, PhenISA,31 derived from the same bisacrylamide
(containing a carboxylic group) and functionalized with a
phenanthroline pendant in its minority part was also prepared.
This allowed decorating the polymer with organometallic
photoluminescent Re, Ru,31 or Ir32 complexes, which could be
exploited for photodynamic therapy (PDT).32
Labeling of PAAs with organometallic luminescent probes
also provides many advantages in comparison to organic
fluorescent dyes, such as high photostability, minimal back-
ground interference, long lifetimes, and high quantum yields.
Moreover, the metal to ligand charge transfer (MLCT)
absorption bands in the visible region allow the excitation of
these compounds at longer wavelengths, which ensures a smaller
light energy dose per cell, implying lower phototoxic effects.
These effects can be maximized when excitation by two-photon
absorption (TPA) is allowed.32−34 In this field, polyimine
Ru(II) complexes have been mostly investigated.35
Because of the prevailingly negative charge at physiological
pH of the PhenISA copolymer, the internalization by HeLa cells
of its Ru derivative was poor.36 For this reason, we recently
developed a new slightly cationic PAA copolymer Ru-complex
(Ru−PhenAN, Chart 1), easily internalized by HeLa cells and
highly effective as a photosensitizer for PDT.36 The polymer
design and composition were optimized in order to include a
phenanthroline pendant to tightly complex the ruthenium
derivative and achieve good solubility while promoting cell
uptake and endosomal escape.
Thus, in this work, we carefully investigated the uptake and
intracellular trafficking of the linear polycationic PAA Ru−
PhenAN. Interestingly, the polymer showed unique trafficking
to the cell nucleus, also at concentrations not associated with
toxicity. Thus, we have carried out detailed live fluorescence
imaging studies to confirm the capacity to access the nucleus in
living cells (in real-time). This, combined with studies on the
potential impact of the cationic polymer on the cell membrane
and lysosomes, has allowed us to investigate in more detail the
mechanisms involved in this unique trafficking behavior.
■ EXPERIMENTAL SECTION
Materials. All chemicals were purchased from Sigma-Aldrich and
used as received, if not otherwise specified. Ultrapure water (Milli-Q,
Millipore, resistivity = 18 M Ω cm−2) was used for the preparation of
the aqueous solutions. N,N′-Bis(acrylamido)piperazine, 4-(4′-amino-
butyl)-1,10-phenanthroline, and Ru(phen)2(OTf)2 were prepared
following literature protocols.31,37 Minimal Essential Medium
(MEM), Dulbecco’s modified phosphate-buffered saline (DPBS),
Trypsin solution (porcine trypsin−EDTA 0.05%), and fetal bovine
serum (FBS) were purchased from Gibco Thermo Fisher Scientific.
Unlabeled 50 nm amino-modified polystyrene nanoparticles (diluted to
10 mg/mL in Milli-Q water) were purchased from Bangs Laboratories
and used as additional controls for some of the assays performed. The
primary antibody against lysosome-associated membrane protein
(LAMP-1, 1 mg/mL solution) and Alexa Fluor 488-conjugated
secondary antibody (2 mg/mL solution) were purchased, respectively,
from Abcam and Thermo Fischer Scientific. The DNA marker 4′,6-
diamidino-2-phenylindole (DAPI) was purchased from Thermo Fisher
Scientific. The viability test reagents 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) and alamarBlue Cell Viability
Reagent were purchased, respectively, from Sigma Aldrich and Thermo
Fisher Scientific. LysoTracker Red DND-99 [1 mM solution in
dimethyl sulfoxide (DMSO)] was purchased from Thermo Fisher
Scientific. Propidium iodide (PI) and sodium azide were purchased
from Sigma-Aldrich. The fluorescent oligonucleotide (ODN) was
synthesized by Biomers.net, upon customer request [base sequence: 5′-
ACTACTACACTAGACTAC-3′,5′-end labeled with ATTO488 fluo-
rescent dye, purified by high-performance liquid chromatography
(HPLC)]. All in vitro tests were performed using polystyrene cell
culture plates purchased from Greiner. Round glass coverslips
(diameter: 12 mm; thickness: 0.13 mm) were purchased from VWR.
Synthesis and Characterization of the Poly(amidoamine)
PhenAN. The polymer used in this work was the same used in a
previous paper36 (Mn = 34,627 Da;Mw = 48,050 Da, PD = 1.38); yield
75%. A second preparation produced PhenAN with a minor average
molecular weight (Mn = 11,912, Mw = 13,577, PD = 1.14); yield 90%.
Size exclusion chromatography (SEC) traces were obtained with Toso-
Haas TSK-gel G4000 PW and TSK-gel G3000 PW columns connected
in series using a Waters model 515 HPLC pump equipped with a
Knauer autosampler 3800, a light scattering (LS) Viscotek 270 dual
detector, UV detector Waters model 486 operating at 230 nm, and a
refractive index detector Waters model 2410 (mobile phase: 0.1 M Tris
buffer pH 8.00; flow rate: 1 mL/min; sample concentration: 1%
solutions). Dynamic LS (DLS) measurements were performed using a
Malvern Zetasizer Nano ZS instrument at 25 °C, at polymer
concentrations 1 mg/mL. Nuclear magnetic resonance (NMR)
experiments were performed on a Bruker DRX400 spectrometer
equipped with a Bruker 5 mm BBI Z-gradient probe head with a
maximum gradient strength of 53.5 G/cm.
Synthesis of Polymer Complex Ru−PhenAN. PhenAN (56 mg,
0.0078 mmol of minor monomer) was dissolved in 2.5 mL of milli-Q
water. Ru(phen)2(OTf)2 (6.8 mg, 0.0090 mmol) was added to the
aqueous solution and mixed. Then, the solution was heated at 50 °C for
60 min in a microwave reactor, after the pH was adjusted at 6 by adding
a few drops of NaOHorHCl 1M. After the reaction was completed, the
solution showed intense red color and exhibited orange luminescence
when excited by 366 nm UV light. The excess Ru(phen)2(OTf)2 was
removed first by treating the mixture with NaOH until pH 10, giving
rise to the unsoluble product Ru(phen)2(OH)2 easily recovered by
centrifugation and then by dialysis of the supernatant solution using a
10,000 molecular weight cutoff membrane. After purification, the
solution showed a bright yellow color and its photoluminescence was
preserved. The dialyzed solution was eventually lyophilized, affording a
yellow, fluffy solid (40 mg, yield 72%). UV−vis absorption spectra were
acquired on an Agilent model 8543 spectrophotometer at room
temperature. Emission spectra were obtained with an Edinburgh
Chart 1. Depiction of the Structure of Polycationic Ru−
PhenAN PAA Derivative
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FLS980 spectrofluorometer equipped with a 450 W xenon arc lamp,
and spectra were corrected for source intensity (lamp and grating) and
emission spectral response (detector and grating) by standard
correction curves. 1H NMR (D2O, 300 K, 9.4 T): δ 8.53 (1H), 8.50
(4H), 8.37 (1H), 8.18 (1H), 8.14 (4H, s), 8.05 (1H), 8.00 (4H), 7.93
(1H), 7.54 (1H), 7.51 (4H), 7.42 (1H), 3.57 (4H), 3.53 (4H), 2.89
(8H), 2.71 (4H).
Cell Culture. HeLa cells (from human cervix adenocarcinoma)
were purchased from the American Type Culture Collection and were
cultured at 37 °C with 5% CO2 in complete medium, obtained by
supplementingMEMwith 10% FBS (50mL of FBS added to 500mL of
MEM). Cultures at ∼80% confluency were routinely split into 75 cm2
polystyrene flasks. Splitting took place every 2−3 days. Cells were used
at passages up to 20 after thawing and tested monthly to exclude
mycoplasma contamination.
Viability Assays. For the alamarBlue assay, cells were seeded in a
96-well plate at a density of 10,000 cells per well and grown for 24 h.
Cells were then exposed to 200 μL of Ru−PhenAN solution in
complete medium for 24 h; then, 20 μL of alamarBlue reagent was
added to each well. After 24 h of incubation with the polymer and
alamarBlue Reagent, 100 μL of the supernatant of each well was
analyzed on a SPECTRAmax spectrofluorometer (excitation: 560 nm,
emission 590 nm). The recorded fluorescence is proportional to the
number of cells; thus, viability was calculated as the ratio between the
fluorescence of the treated cells and untreated control cells (here used
as a negative control) in the same conditions. For the MTT assay, the
cells were seeded in a transparent 96-well plate at a density of 10,000
cells per well and grown for 24 h. The cells were then exposed to 200 μL
of Ru−PhenAN in either complete medium or serum-free medium for
90 min; then, 20 μL of MTT solution (5 mg/mL in DPBS) was added
to each well. After 90 min of incubation, the wells were carefully
emptied and 0.2 mL of DMSO was added to each well to solubilize the
dark precipitate at the bottom of the wells. The plate was analyzed on a
ThermoMax microplate reader, measuring absorbance at 550 nm. As a
positive control, the results obtained in an independent experiment on
HeLa cells seeded and cultured under the same conditions and exposed
to 50 μg/mL of cationic 50 nm amino-modified polystyrene
nanoparticles for 3 h in either complete medium or serum-free medium
are shown. The recorded absorbance is proportional to the number of
cells; thus, viability was calculated as the ratio between the absorbance
of treated cells and untreated control cells (here used as a negative
control) in the same conditions.
Ru−PhenAN Uptake via Flow Cytometry. HeLa cells were
seeded in a 24-well plate, at a density of 60,000 cells per well and grown
for 24 h. Cells were then exposed to Ru−PhenAN in either complete
medium or serum-free medium. At the end of the incubation time, cells
were washed with complete medium and DPBS and then harvested by
incubation with 300 μL of trypsin for 5 min at 37 °C. Trypsin was then
deactivated by the addition of 700 μL of complete medium and the cells
were collected and transferred into a tube. After centrifugation at 300 g
for 4 min, the supernatant was discarded and cells were resuspended in
500 μL of DPBS for flow cytometry.
To measure uptake in energy-depleted cells, the cells were
preincubated in 5 mg/mL NaN3 in complete medium for 30 min;
then, the cells were exposed to 100 μg/mL Ru−PhenAN in complete
medium containing 5 mg/mL NaN3. Additionally, the cells were
preincubated at 5 °C and then exposed to Ru−PhenAN (100 μg/mL)
in complete medium at 5 °C. After exposure to the polymer, the cells
were washed, harvested, and suspended in 500 μL of DPBS for flow
cytometry analysis.
The cells were analyzed on a BD LSR-II flow cytometer (excitation
laser: 450 nm; fluorescence channel: 615/20). Data were analyzed with
FlowJo software. Forward and side scattering dot plots were used to
discriminate cellular debris. A minimum of 20,000 cells (unless
specified differently) were acquired for each sample in order to obtain
cell fluorescence distributions. In the experiments at 5 °C, it was not
always possible to record 20,000 viable cells, but for all samples a
minimum of 5000 cells were acquired. For all conditions, three
technical replicates were prepared for each sample and results are
reported as the average and standard deviation over the three replicates
of the median cell fluorescence intensity.
Ru−PhenAN Uptake via Confocal Imaging. HeLa cells were
seeded in a 24-well plate equipped with glass coverslips at a density of
60,000 cells per well and grown for 24 h. The cells were then exposed to
Ru−PhenAN in complete medium. After exposure, the cells were
washed with complete medium and DPBS, fixed, and permeabilized by
incubation with ice-cold methanol for 5 min. Lysosomes were stained
with a primary antibody against LAMP1 and a green Alexa Fluor 488-
labeled secondary antibody; the nuclei were stained with DAPI. The
cells were imaged on a Leica TCS SP8 confocal microscope equipped
with a 60× oil objective (DAPI excitation: 405 nm laser; DAPI
detector: 420−460 nm. Alexa Fluor 488 excitation: 488 nm laser; Alexa
Fluor 488 detector: 500−550 nm; Ru−PhenAN excitation: 405 nm;
Ru−PhenAN detector: 580−800 nm). The images were analyzed with
ImageJ software. All series were taken using the same settings (laser
power, voltage of photomultiplier tubes, gain, etc.) to allow a
quantitative comparison for the different conditions. Unless differently
specified, all images were acquired adjusting settings to ensure
confocality.
Live Cell Imaging. HeLa cells were seeded at a density of 100,000
cells per microscope dish (35 mm glass bottom dishes, MatTek) and
incubated at 37 °C in 5% CO2 for 24 h. Then, cells were exposed to 1
mL of Ru−PhenAN at the required concentration in complete medium.
The sample was imaged straight away with a DeltaVision Elite
microscope. Parameters: objective 100×; laser power 10%; Ru−
PhenAN excitation: 532; Ru−PhenAN emission: 576 (TRITC
Channel). Alternatively, the sample was imaged with a Leica SP8
confocal microscope, opening the pinhole size to 2.0 airy units to
increase the recorded signal. Images were acquired every 5 s for up to 10
min. Parameters: 60× oil-immersion objective; DAPI excitation: 405
nm laser; DAPI detector: 420−460 nm; Ru−PhenAN excitation: 405
nm; Ru−PhenAN detector: 580−800 nm.
Flow Cytometry-Based Assays. PI Assay.HeLa cells were seeded
in a 24-well plate at a density of 80,000 cells per well and grown for 24 h.
The cells were then exposed to Ru−PhenAN in either complete
medium or serum-free medium for 3 h, washed once with serum-free
medium, and then incubated with a PI solution (35 μg/mL in serum-
freemedium) for 20min. The cells were washed with completemedium
andDPBS, harvested with trypsin, and eventually resuspended in DPBS
for flow cytometry analysis on a BD FACS Array (excitation laser: 532
nm; fluorescence channel: 585/42). As a positive control, untreated
HeLa cells were harvested, fixed, and permeabilized by incubation with
ice-cold 100% methanol for 5 min, washed with DPBS, and incubated
with a PI solution (35 μg/mL in serum-free medium) for 20 min before
flow cytometry analysis. Data were analyzed with FlowJo software.
Forward and side scattering dot plots were used to discriminate cellular
debris. A minimum of 20,000 cells (unless specified differently) were
acquired for each sample in order to obtain cell fluorescence
distributions. Three technical replicates were prepared for each sample
and results are reported as the average and standard deviation over the
three replicates of the median cell fluorescence intensity.
LysoTracker Assay. HeLa cells were seeded in a 24-well plate at a
density of 80,000 cells per well and grown for 24 h. Then, cells were
exposed to Ru−PhenAN in complete medium and afterwards washed
with complete medium and DPBS, harvested with trypsin, and
incubated with a LysoTracker solution (50 nM in complete medium)
for 15 min. The cells were eventually resuspended in 100 μL of DPBS
for flow cytometry analysis on a BD FACS array as detailed above. As a
positive control, in an independent experiment, HeLa cells were
exposed to different concentrations of cationic 50 nm amino-modified
polystyrene nanoparticles for 24 h in complete medium and then
incubated with LysoTracker and analyzed as detailed above.
Statistical Analysis. For all experiments, three technical replicate
samples were prepared for each condition and the results are the
average and standard deviation over the three technical replicates. All
experiments were repeated multiple times to confirm the outcomes. In
order to compare two sets of data, a Student’s t-test was used to
determine statistically significant differences: the results of the two sets
of data were considered significantly different when the resulting p-
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value was <0.05. Statistically significant differences are marked with an
asterisk (*).
■ RESULTS AND DISCUSSION
We have recently reported on the synthesis as well as the
chemical and photophysical characterization of a linear
polycationic PAA complexed with a luminescent tris-phenan-
throline Ru complex, called Ru−PhenAN (Chart 1), which is at
the basis of this investigation.36
The polymer can be produced with different molecular
weights, depending on the time left to the reaction mixture and
on the temperature. Reactions with longer times at lower
temperature allow producing smaller polymers (by SEC analysis
Mn = 11,912, Mw = 13,577, polydispersity index = 1.14), with
respect to the one obtained previously.36 The polymer is
characterized by twomean pKa values (pKa1 = 3.35, pKa2 = 7.40)
that make the polymer cationic below a pH value of 7.40, and
instead only slightly positive (about 25% of the repeating units)
at physiological pH.36 Polycationic polymers have been shown
to promote endosomal escape and it is known that their overall
charge and buffering capacity are at the basis of endosomal
escape mechanisms promoted by the so-called proton sponge
effect,38 even though other theories and mechanisms of escape
by cationic species have been proposed in the literature.18
Figure 1. Uptake and viability of HeLa cells exposed to Ru−PhenAN. (a) Top panel: uptake of Ru−PhenAN in cells exposed to different
concentrations of the compound in complete cell culture medium supplemented with 10% FBS (19 h of exposure). Bottom panel: examples of the
corresponding cell fluorescence intensity distributions. (b) Top panel: comparison of the uptake kinetics by flow cytometry of Ru−PhenAN (30 μg/
mL) in serum-free medium (blue line) and in complete cell culture medium supplemented with 10% FBS (red line). Bottom panels: examples of the
corresponding cell fluorescence intensity distributions in serum-free medium (left) and in medium supplemented with 10% FBS (right). Values and
error bars are the average and standard deviation over three replicates of the median cell fluorescence intensity. (c) Viability of cells (assessed via
alamarBlue assay) exposed to different concentrations of Ru−PhenAN for 48 h in complete cell culture medium supplemented with 10% FBS. Values
and error bars are the mean and standard deviation over three replicates. The results are expressed as a percentage with respect to untreated cells not
exposed to Ru−PhenAN, here used as the negative control (−). An unpaired Student’s t-test was used to determine statistically significant differences
in comparison to untreated cells (negative control). Statistically significant differences (p-value <0.05) are indicated with an asterisk (*). (d)
Intracellular accumulation of Ru−PhenAN assessed via confocal fluorescence microscopy on fixed cells. Blue: DAPI-stained nuclei; green: LAMP-1-
stained lysosomes; red: Ru−PhenAN. Cells exposed to Ru−PhenAN at a concentration of 30 μg/mL for 3 h. Left panels: Ru−PhenAN channel only.
Right panels: composite images of the three channels. Images of control untreated cells recorded with the same settings are also included to confirm
that no signal in the Ru channel was detected.
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Overall, the mild cationic character of PhenAN at physiologic
pH contributes to limit its toxicity while enabling the polymer to
cross cell barriers and promote escape.39,40
In order to label the polymer to quantify and visualize its
uptake and cellular trafficking, the PhenAN copolymer was
conjugated to a luminescent ruthenium-based complex
(Supporting Information Figure S1). Polyimine Ru(II)
complexes bearing three chelating phenanthroline ligands are
very useful for cell imaging, as they also show a large absorption
band in the wavelength window usually used to excite common
organic fluorescent dyes employed in confocal microscopy
(400−500 nm, Supporting Information Figure S1).36 It is
noteworthy that this class of complexes can also be excited by
TPA, which is an important feature for biological applications
because of the reduced energy associated with the employed
NIR light source, thus the lower phototoxicity.
Characterization of PhenAN and Ru−PhenAN in
Relevant Media. The PhenAN polymer and its Ru-based
derivative Ru−PhenAN were previously characterized in water
by employing several techniques such as DLS, transmission
electron microscopy, and NMR to gain information about their
stability and size. It is indeed well known that PAAs tend to self-
assemble in water forming nanoaggregates of variable
sizes.21,31,41 The results indicated that the polymer formed
aggregates of around 20 nm with a smaller fraction of objects of
around 90 nm.36
Conversely, DLS of the polymer in saline water showed a
mean hydrodynamic diameter of about 200 nm (by intensity, see
Supporting Information Figure S2): neither pH changes (from
3.5 to 8.7) nor the time after the dissolution of the lyophilized
polymer caused any variation of the size distribution profile,
indicating good stability of the agglomerates over time.
We also characterized the polymer in PBS by nanoparticle
tracking analysis (NTA, Supporting Information Figure S3).
NTA can partially overcome some limitations of DLS for
polydisperse samples, but for poorly scattering materials it
cannot easily detect sizes below 100 nm. NTA results showed
average sizes of around 120 nm in PBS and allowed us at least to
exclude the presence of larger aggregates.
The dispersions of the polymer in a cell culture medium with
serum were also characterized. It is known that in biological
fluids, nanosized materials can become unstable because of the
high ionic strength of these media,42,43 and furthermore, they
can adsorb proteins and biomolecules present in the
surrounding environment.18,44,45 It is thus important to ensure
that the sample remains stable in the conditions used for cell
experiments. DLS in these complex media can become
extremely challenging because of the presence of the proteins,
especially for polymers such as the one studied here, which
already showed limited scattering when dispersed in water.
Indeed, multiple peaks were determined by DLS, possibly
because of limited scattering or suggesting agglomeration (data
not shown). To further elucidate this, NTAwas again used to (at
least) exclude the presence of strong agglomeration in these
conditions. The results showed a main peak shifted to slightly
larger values (around 160 nm) than what was measured in PBS,
possibly because of the adsorption of proteins on the polymer
(see Supporting Information Figure S3). Importantly, no
presence of aggregates was detected, overall suggesting that
the polymer was stable also in complete cell culture medium.
Uptake and Intracellular Trafficking of Ru−PhenAN in
Fixed and Live Cells. HeLa human cervical cancer epithelial
cells were chosen as a common model system to study uptake
and intracellular trafficking of the Ru−PhenAN polymer.
The presence of the ruthenium complex allowed quantifica-
tion of uptake by cells via flow cytometry. The results showed
that the polymer was internalized, and uptake increased with the
polymer dose and exposure time, as commonly observed for
similar materials (Figure 1a,b). We also compared the uptake of
the polymer added to cells in complete medium with and serum-
free medium and interestingly we found no major differences in
the uptake efficiency in the two conditions (Figure 1b): it is
known that the adsorption of proteins on nano-sized particles
(forming the so-called nanoparticle corona) typically leads to a
much lower uptake into cells in comparison to what is observed
when bare nanomaterials are exposed to cells in the absence of
proteins.46−50 Thus, the fact that for this polymer no major
differences in uptake levels were observed in the two conditions
is rather peculiar and may suggest that proteins are only loosely
associated to the polymer surface, and, because of this, they do
not affect the final interactions with cells. Further studies are
required to explain this observation.
Cell viability measurements after 48 h of exposure
(alamarBlue assay, Figure 1c) showed little or no toxicity for
cells exposed up to 30 μg/mL polymer and some toxicity at the
higher concentrations tested, with 50% reduction of viability for
cells exposed to 100 μg/mL polymer. It was previously shown
that because of their pKa, even at low lysosomal pH (∼4.5) PAAs
comparable to the major component of Ru−PhenAN are only
partially protonated; thus, they possess only a mild cationic
character. This is an important feature of these polymers, which
makes them typically much less toxic than many other cationic
polymers, such as polylysine, that at low pH are fully
protonated.51,52
Interestingly, confocal fluorescence microscopy of fixed cells
showed accumulation of the polymer in the nucleus in all cells
(Figure 1d). The same was observed also in cells without DAPI
staining, thus excluding spillover of the DAPI signal in the
polymer channel (Supporting Information Figure S4) and using
a different microscope (Supporting Information Figure S5).
Similar results were observed also in a primary cell line, namely,
in human umbilical vein endothelial cells exposed to Ru−
PhenAN after fixation (Supporting Information Figure S6).
Accumulation at the nuclear level was confirmed also for a
second Ru−PhenAN batch (Supporting Information Figure
S7), which was prepared using a smaller copolymer (∼12 kDa vs
∼30 kDa, see Experimental Section). PAAs are extremely stable
in physiological conditions, being resistant to proteases and
hydrolyzing very slowly in the pH range 5−7.4.53 Thus, we can
exclude that the signal observed at the nuclear level comes from
smaller degradation products and even if the ruthenium moiety
would detach from the phenanthroline present in the main
polymer, it would fully lose its capacity to fluoresce. Addition-
ally, we previously prepared a small ruthenium complex,
analogous to that carried by Ru−PhenAN, but devoid of the
polymer chain (for the sake of clarity its structure is shown in
Scheme S1 of the Supporting Information), and we showed that
it was not accumulating at the nuclear level,36 even when
exposing cells to a Ru complex concentration 100 times higher
than the molarity of the ruthenium present in 30 μg/mL Ru−
PhenAN. Thus, the rutheniummoiety alone is not able to access
the nucleus. Interestingly, we also prepared a fluorescent
PhenAN polymer endowed with a rhodamine pendant and
lacking the ruthenium complex (see Supporting Information
and Figures S8−S11 for details) and showed that in fixed cells
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this polymer was unable to reach the nucleus and remained
confined in cellular vesicles (Supporting Information Figure
S12). Thus, altogether, these observations suggested that the
observed signal in the nuclei is due to the nuclear accumulation
of the Ru−PhenAN polymer in its entirety, and that both the
main polymer chain and the ruthenium-based pendant play an
important role in the capacity of Ru−PhenAN to translocate to
the nucleus.
It is important to mention that for some cationic molecules,54
chemical fixation can create artifacts, in which endosomal escape
and/or accumulation at the nuclear level of positive compounds
is observed solely as a consequence of the membrane damage
(endosomal and/or nuclear) induced by the fixation. It is also
true that some cationic objects do not show such capacity even
after destabilization of membranes by fixation, as for instance we
observed here for the PhenAN polymer without the ruthenium
complex, labeled with rhodamine (Supporting Information
Figure S12). Thus, in order to confirm the capacity of Ru−
PhenAN to escape the endosomes and/or access the nucleus, we
performed additional studies by live cell imaging. Interestingly,
as we previously observed,36 live cell imaging showed a
progressive increase of the polymer signal at the nuclear level
in individual cells after only 20 min exposure, while only a few
vesicles containing the polymer could be detected (Figure 2a,
with quantification of nuclear fluorescence in Figure 2b, and
corresponding Supporting Video S1).
It is known that some ruthenium complexes can increase their
fluorescence signal sensibly when intercalated in DNA35,55 and
that the MLCT luminescence of Ru(phen)3
2+-like complexes
can strongly be affected by the binding of the complexes to DNA
strands.56 Similar phenomena could explain or at least
contribute to the observed predominance of the signal at the
nuclear level. In order to test whether similar effects could be
present also in our case, cellular DNAwas titrated into a polymer
solution and its fluorescence emission recorded after 3 h of
interaction. The results (Supporting Information, Figure S13)
clearly confirmed that the addition of DNA does increase the
emission of Ru−PhenAN (to a level comparable to the signal
recorded for a polymer solution roughly 6 times more
concentrated, data not shown). It is likely that DNA
condensation, together with other unique environmental
conditions in the nucleus (including, for instance, lower oxygen
levels and a greater stiffness with respect to the other cellular
suborganelles), further increases this phenomenon in cells.
Uptake of Ru−PhenAN in Energy-Depleted Cells,
Impact on Lysosomes, and the Cell Membrane. The
limited presence of intracellular vesicles containing the polymer
at shorter exposure times could also be interpreted as a sign of a
mechanism of uptake via fusion with the cell membrane and
direct access to the cytosol and later the nucleus, rather than
uptake via endocytosis into endosomes and a later mechanism of
endosomal escape (even though a fraction of lysosomes
containing the polymer were present). In order to test this
and to determine whether uptake occurred via active processes
such as endocytosis, cells were depleted of energy by exposure to
sodium azide or by incubation at 5 °C. The results (Figure 3)
Figure 2.Cellular localization of Ru−PhenAN in live HeLa cells. HeLa cells were incubated with 30 μg/mL Ru−PhenAN in complete medium for 1 h.
Then, live cells were imaged every 30 s for a total of 20 min on a DeltaVision Elite fluorescence wide field microscope. (a) Images show that the nuclear
signal of Ru−PhenAN increases over time. Top: merged bright-field image and Ru−PhenAN fluorescence signal (red). Bottom: Ru−PhenAN
fluorescence signal only (white). Scale bar: 25 μm. The corresponding Video S1 is included in the Supporting Information. (b) Fluorescence intensity
(raw integrated density) in eight arbitrary selections of the same size taken from the image shown on the left. Left image: the areas selected for the
calculation of the fluorescence intensities are indicated with yellow circles. Right graph: fluorescence intensity over time of the areas selected.When the
nuclei were selected (black symbols, nuclei), an increase in signal over time wasmeasured.When regions outside the nuclei were selected (red symbols,
background), the signal remained constant over time. This quantification confirmed an increase in Ru−PhenAN fluorescence inside the nuclei upon
illumination, as observed in panel a and the corresponding Supporting Video S1.
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showed that uptake was blocked by energy depletion, clearly
excluding the possibility for a passive uptake via a fusion
mechanism with the cell membrane. It seems unlikely that other
forms of active transport, such as, for instance, via active
transporters present in cells for direct access of ions and small
molecules to the cytosol, could be able to internalize large
polymers such as the one used here. Thus, the results suggested
that the polymer accumulates into cells via active uptake and is
trafficked along the endo-lysosomal compartments prior to
reaching the nucleus.
As some cationic polymers accumulating in the endo-
lysosomal compartment are known to strongly alter the
lysosomes,57 LysoTracker staining was used to determine
whether similar effects could be observed also in cells exposed
to Ru−PhenAN (Figure 4). Some cationic particles and
polymers can, in fact, induce damage to lysosomal membranes,
leading to lysosomal swelling or rupture (associated with a
Figure 3.Uptake of Ru−PhenAN assessed via flow cytometry in standard conditions (37 °C, red) and in energy-depleted conditions. HeLa cells were
depleted of their energy by supplementing the cell culture mediumwith 5mg/mLNaN3 (green) or by incubation at 5 °C (blue). (a) Uptake kinetics of
Ru−PhenAN in the three conditions. Values and error bars are the average and standard deviation over three replicates of the median cell fluorescence
intensity (error bars are not visible because the standard deviation is too small). (b) Same results are shown after normalization for the uptake in
standard condition (37 °C). An unpaired Student’s t-test was used to determine statistically significant differences in comparison to uptake in standard
conditions. Statistically significant differences (p-value <0.05) are marked with an asterisk (*).
Figure 4. (a) LysoTracker intensity distributions by flow cytometry of HeLa cells exposed to different concentrations of Ru−PhenAN. At 3 h (blue
distributions), the LysoTracker intensity was slighlty lower than in control untreated cells (red, negative control). At 24 h (orange), two
subpopulations were visible, more and less fluorescent than control cells, respectively. (b) Corresponding LysoTracker median fluorescence intensity
of cells exposed to Ru−PhenAN for 3 h (blue) and 24 h (red). Values and error bars are the average and standard deviation over three replicates of the
median cell fluorescence intensity. An unpaired Student’s t-test was used to determine statistically significant differences in comparison to the results in
untreated cells. Statistically significant differences (p-value <0.05) are marked with an asterisk (*). As a positive control, the results obtained in cells
exposed to cationic 50 nm amino-modified polystyrene nanoparticles are shown in the Supporting Information, Figure S14. (c) Corresponding
percentage of cells with loss of LysoTracker staining (% altered population) after 24 h of incubation with Ru−PhenAN.
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strong increase of LysoTracker intensity or loss of LysoTracker
staining, respectively), which could contribute to the mecha-
nism of endosomal and lysosomal escape. Indeed, cells exposed
for 24 h to amino-modified polystyrene nanoparticles were used
as a positive control for similar effects and showed increased
LysoTracker staining, together with a second subpopulation of
cells with loss of LysoTracker staining (Supporting Information
Figure S14). Instead, after 3 h of exposure to Ru−PhenAN, only
a mild decrease in LysoTracker intensity was detected, possibly
suggesting a small buffering effect of the polymer on the
lysosomal acidity due to its positive charge. Only after 24 h of
exposure, a small increase in LysoTracker intensity was
observed, together with a small percentage of cells with loss of
LysoTracker, possibly as a consequence of lysosomal damage or
simply because of the observed toxicity at this time scale for cells
exposed to these polymer concentrations (Figure 1d). Overall,
however, in comparison to what was observed for other cationic
nanoparticles such as the amino-modified polystyrene (Support-
ing Information Figure S14),56 no major lysosomal alterations
were observed. Similarly, immunostaining of the lysosomes did
not show any obvious increase in lysosomal size (Figure 1c).
Given the positive charge of the polymer, we also investigated
whether exposure to the polymer was associated with damage to
the negatively charged cell membrane. To this aim, wemeasured
cell membrane permeability to PI after exposure to the polymer
in complete medium (containing 10% FBS) as well as in serum-
free medium, where the positive charges are not screened by
serum protein absorption. We stress that serum-free conditions
are artificial laboratory conditions not relevant to biological
applications but can be helpful in understanding nanocarrier
behavior by comparison. No increase in PI permeability and no
decrease in cell viability were observed after 3 h of exposure to
concentrations up to 100 μg/mL in the cell culture medium
containing serum (Figure 5). Interestingly, even in serum-free
conditions, only amild effect on cell membrane permeability was
observed by PI staining, accompanied by a decrease in cell
viability. The mild impact to the cell membrane of the bare
polymer in artificial serum-free conditions further confirms its
mild cationic character. This is one of the amenable features of
Figure 5. Impact of Ru−PhenAN on the cell membrane. (a) PI permeability test by flow cytometry after 3 h of exposure to Ru−PhenAN (30 μg/mL)
in serum-free conditions (blue) and in complete cell culture medium supplemented with 10% FBS (red). As a negative control (−), untreated cells that
were not exposed to Ru−PhenAN were used, and as a positive control (+), cells that were fixed and permeabilized using methanol and then stained by
PI were used (see Experimental Section for details). Values and error bars are the average and standard deviation over three replicates of themedian cell
fluorescence intensity. (b) Viability of cells (assessed via MTT assay) exposed to different concentrations of Ru−PhenAN for 3 h in complete cell
culture medium supplemented with 10% FBS (red) or in serum-free medium (blue). The results are normalized by the values obtained for untreated
control cells. As a negative control (−), the viability of untreated cells not exposed to Ru−PhenAN was used and as a positive control (+), the viability
of cells that were exposed for 3 h to 50 μg/mL cationic 50 nm amino-modified polystyrene nanoparticles in complete cell culture medium
supplemented with 10% FBS or in serum-free medium was used. Values and error bars are the average and standard deviation of the results obtained
over three replicates. An unpaired Student’s t-test was used to determine statistically significant differences in comparison to PI fluorescence and
viability in untreated cells (negative control). Statistically significant differences (p-value <0.05) are marked with an asterisk (*). The results showed
that Ru−PhenAN induced some cell membrane damage only when added to cells in serum-free conditions.
Figure 6.Cellular localization of Ru−PhenAN in liveHeLa cells depends on the sample illumination. Cells were exposed to 30 μg/mL Ru−PhenAN in
complete medium for 24 h in the dark and then imaged on a Leica SP8 confocal microscope, opening the pinhole size to 2.0 airy units to increase the
recorded signal. Before acquiring the image, the sample area delimited by the yellow line was illuminated every 5 s for 10 min using the microscope
laser, while the area within the blue line was not illuminated. Only in the illuminated area was the Ru−PhenAN signal at the nuclear level observed,
whereas it remained confined in vesicles in the non-illuminated area. Scale bar: 50 μm.
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PAAs for drug delivery in comparison to other cationic species,
which show much stronger damage because of the direct
interaction of their bare cationic surface to the cell membrane.56
Light-Triggered Mechanism of Escape and Accumu-
lation at the Nuclear Level.On the base of all these pieces of
evidence (i) energy-dependent uptake (Figure 3), (ii) no
obvious alterations of the acidic compartments stained by
LysoTraker (Figure 4); (iii) no evident damage to the cell
membrane due to the cationic character (Figure 5), we would
expect to observe a more substantial number of intracellular
vesicles stained by the polymer prior to the accumulation at the
nuclear level observed in live cells. As this was not the case
(Figure 2), we hypothesized that the light, during the
observation, could have a role and trigger the release of the
polmyer from intracellular vesicles. In fact, the Ru complex can
act as a photosensitizer for singlet oxygen production,36 and
these are well-known cytotoxic species that can destabilize lipid
membranes. To test this hypothesis, we exposed cells for 24 h to
30 μg/mL Ru−PhenAN in complete medium under standard
culturing conditions in the dark. Then, we took a fast snapshot
image of the live cells. This allowed us to detect that, in the dark
and in the very first instants of illumination, the polymer was
present in a large number of intracellular vesicles, as expected
after endocytosis, andimportantlyin these dark conditions
no signal at the nuclear level was visible (Supporting
Information, Figure S15). Then, during the illumination, we
saw a change in the subcellular localization of the emitted signal
and increasing signal at the nuclear level (Video S2). The effect
is evident in Figure 6, where the field of view was adjusted to
allow capturing in the same snapshot both the area illuminated
for 10 min (1 frame every 5 s) and a neighboring area that was
not illuminated. These results clearly indicated that Ru−
PhenAN remained confined in vesicles in the dark following
endocytosis, while instead it accumulated in the nuclei only
upon illumination. We also stress that accumulation at the
nuclear level upon illumination was observed both when
imaging live cells using a wide field fluorescence microscope
(Figure 2) and when using a confocal microscope (as shown
here in Figure 6), thus further confirming our observations even
when using different instruments.
Without illumination, some degree of accumulation at the
nuclear level in live cells was observed only in HeLa cells treated
with much higher doses of Ru−PhenAN (300 μg/mL for 4 h)
(Supporting Information, Figure S16). It is likely that in these
conditions, the cationic character of the polymer enables
accumulation at the nuclear level in some cells, probably simply
as a consequence of the strong toxicity induced at these higher
concentrations (Figure 1d), limiting their applicability overall.
In contrast, upon illumination, accumulation at the nuclear level
was achieved in all cells and using polymer concentrations for
which no toxicity was observed. Similarly, even after the light-
triggered escape and accumulation at the nuclear level, no
evident signs of toxicity and cell death were observed in the
imaged cells. Nevertheless, it will be important in future to
further tune polymer design and illumination conditions in
order to promote escape and achieve accumulation at the
nuclear level while fully excluding side toxicity because of singlet
oxygen production.
Finally, we performed preliminary studies on fixed cells where
a fluorescently labeled ODN, here used as a model of genetic
material, was complexed with increasing amounts of Ru−
PhenAN to test whether the polymer was able to carry such
compounds to the nucleus. In fixed cells, access to the nucleus of
both the polymer and theODNwas achieved only for complexes
formed at lower ODN amounts (lower ODN/Ru−PhenAN
ratios, Supporting Information, Figure S17). Further studies are
required to test whether the polymer shows a similar behavior on
live cells.
■ CONCLUSIONS
Delivering drugs to the precise intracellular location of their
molecular target remains one of the major barriers in drug
delivery. The cell cytosol and the nucleus often need to be
reached by drugs, while most nano-sized drug carriers
accumulate along the endo-lysosomal pathway, where they
remain trapped. Several strategies for endosomal escape and
access to the nucleus are being investigated and often suffer from
limited efficacy or can be accompanied by strong toxicity.
Here, we report a novel linear PAA capable to reach the cell
nucleus with very high efficiency even at low concentrations, for
which no toxicity is observed. This mildly cationic polymer
enters cells without evident membrane damage via an energy-
dependent uptake process (possibly endocytosis).
Then, upon illumination, Ru−PhenAN is capable to trans-
locate to the nucleus, with some cells showing a polymer signal
at the nuclear level already after only 20 min of exposure. The
observed endosomal escape hence seems to be triggered by the
illumination of the photoactive Ru complex carried by the
polymer, suggesting a mechanism of escape and access to the
nucleus via membrane damage due to the production of singlet
oxygen by Ru. Nevertheless, the Ru complex alone is not able to
move to the nucleus.36 Thus, the mild cationic charge of the
polymer is likely to facilitate the escape mechanism. At the same
time, the cationic character alone is not enough to achieve
accumulation at the nuclear level either, as for cells kept in the
dark nuclear access was observed only after exposure to much
higher polymer concentrations, probably as a consequence of
the strong toxicity observed in these conditions. Finally, the
results suggested that the Ru moiety not only enables a light-
triggered mechanism, but is also essential to achieve the nuclear
accumulation of the polymer, probably because of effects on
polymer folding and conformation, since, in contrast, the same
PhenAN endowed with a rhodamine moiety remained confined
into intracellular vesicles without accessing the nucleus.
Overall, based on these observations, we can conclude that the
ability to reach the nucleus is due to the combination of two
main factors: the mild cationic character of the polymer together
with the photophysical properties of the Ru complex appended
to each polymer coil. Each of these two factors is necessary but
not sufficient, and only when both are present it is possible to see
a very efficient translocation to the nucleus.
Past studies on amphoteric PAAs suggested that these
polymers could selectively damage biological membranes at
low pH only,39 possibly inducing the release of the endosome/
lysosome content without a complete swelling of the intra-
cellular vesicles. Anyhow, as previously mentioned, the detailed
mechanisms of endosome membrane destabilization and escape
remain poorly understood also for other polyelectrolytes such as
polyethylenimine, and debate is still on-going even on the
existence of the so-called proton-sponge effect and nature of
other possible mechanisms.18
Similarly, it remains to be elucidated how such a relatively
largemolecule is capable to enter the nucleus. Again, we can only
speculate a role for the soft linear nature of the polymer coils.
Further studies are needed to fully address this aspect, as also to
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confirm the capacity of this polymer to bring drugs or small
oligos to the cytosol and/or nucleus in live cells.
Concerning the observed toxicity in the dark, we note that the
measured IC50 dose (about 100 μg/mL) is much higher than for
other polycationic non-viral vectors and more importantly
access to the nucleus is achieved even at concentrations 10 times
lower, for which no toxicity could be detected. Regardless of this,
even though these preliminary data suggested that the light-
triggered escape was not accompanied by evident toxicity,
further studies are required to fully exclude side effects due to
singlet oxygen production. Tuning PAA design is indeed rather
easy: for instance, the addition of a minority percentage of
amphoteric repeating units able to modulate the overall positive
charge and further lower it could help to lower the observed
toxicity and similarly the number of ruthenium moieties could
be controlled in order to achieve light-triggered behavior
without side toxicity. The possibility of triggering escape and
access to the nucleus upon illumination opens up exciting
perspectives for the use of these classes of polymers for targeted
delivery. Indeed, molecular targeting by functionalization of
drug carriers with antibodies and other similar targetingmoieties
remains highly challenging,9 while the possibilities to engineer
stimuli-responsive drug carriers is receiving increasing attention
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